It took about two decades after micro and milli reactor technology has reached the production scale with significant production volumes. Now, curiosity and openness of chemical companies grow significantly to benefit from this technology’s potentials like access to new and better products, increased process performance and significantly better process safety.
Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.
The EU Chemicals Strategy for Sustainability (CSS) highlights the shift to a hazard-centric approach in EU chemical regulation, emphasizing 'Substance of Concern' over risk-based measures.
The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.
In an interview with CHEManager, Edgardo Hernandez, President of Lilly Manufacturing, explains the strategy behind the ambitious investment project.
The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle.
